Mesa Laboratories (NASDAQ:MLAB) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened

Key Points

• Technical breakout: Mesa Laboratories' shares crossed above their 200-day moving average (200‑DMA $85.01), trading as high as $109.49 and last at $106.12 on volume of 121,638.
• Earnings beat: The company reported quarterly EPS of $3.07 (vs. $2.41 expected) and revenue of $65.13M (vs. $63.23M), while sell-side analysts project roughly $7.26 in EPS for the current fiscal year.
• Mixed analyst view and insider activity: Despite some upgrades, the consensus rating is "Reduce" with an average target of $94, insiders purchased about 6,116 shares last quarter, and institutional investors own roughly 90.6% of the stock.

Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report)'s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $85.01 and traded as high as $109.49. Mesa Laboratories shares last traded at $106.12, with a volume of 121,638 shares traded.

Analysts Set New Price Targets

MLAB has been the subject of a number of research analyst reports. Zacks Research raised Mesa Laboratories from a "strong sell" rating to a "hold" rating in a report on Friday, January 9th. Weiss Ratings restated a "sell (d+)" rating on shares of Mesa Laboratories in a research report on Monday. Wells Fargo & Company boosted their price objective on Mesa Laboratories from $83.00 to $94.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 4th. Finally, Wall Street Zen upgraded Mesa Laboratories from a "buy" rating to a "strong-buy" rating in a research report on Saturday, February 7th. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Reduce" and an average target price of $94.00.

Mesa Laboratories Price Performance

The firm has a market cap of $586.31 million, a P/E ratio of 165.82 and a beta of 0.94. The company has a current ratio of 1.94, a quick ratio of 1.45 and a debt-to-equity ratio of 0.86. The business has a 50-day moving average of $91.53 and a two-hundred day moving average of $85.01.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 3rd. The medical instruments supplier reported $3.07 earnings per share for the quarter, topping analysts' consensus estimates of $2.41 by $0.66. The business had revenue of $65.13 million for the quarter, compared to analyst estimates of $63.23 million. Mesa Laboratories had a return on equity of 22.02% and a net margin of 1.51%. On average, sell-side analysts anticipate that Mesa Laboratories, Inc. will post 7.26 earnings per share for the current fiscal year.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Friday, May 29th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, May 29th. Mesa Laboratories's payout ratio is 100.00%.

Insider Buying and Selling at Mesa Laboratories

In related news, Director Shiraz Shabanali Ladiwala purchased 3,500 shares of Mesa Laboratories stock in a transaction on Tuesday, March 10th. The shares were purchased at an average price of $72.23 per share, for a total transaction of $252,805.00. Following the transaction, the director owned 8,523 shares of the company's stock, valued at approximately $615,616.29. This represents a 69.68% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Mark Christopher Capone purchased 1,301 shares of Mesa Laboratories stock in a transaction on Tuesday, March 10th. The stock was bought at an average price of $76.35 per share, for a total transaction of $99,331.35. Following the transaction, the director directly owned 3,429 shares in the company, valued at approximately $261,804.15. The trade was a 61.14% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have purchased 6,116 shares of company stock worth $452,076. Insiders own 4.90% of the company's stock.

Institutional Investors Weigh In On Mesa Laboratories

A number of institutional investors have recently made changes to their positions in MLAB. Northwestern Mutual Wealth Management Co. grew its position in shares of Mesa Laboratories by 5,366.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier's stock valued at $26,000 after buying an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Mesa Laboratories in the 4th quarter valued at about $27,000. Farther Finance Advisors LLC lifted its stake in shares of Mesa Laboratories by 17,733.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 535 shares of the medical instruments supplier's stock valued at $36,000 after purchasing an additional 532 shares during the period. CWM LLC lifted its stake in shares of Mesa Laboratories by 48.9% in the 3rd quarter. CWM LLC now owns 597 shares of the medical instruments supplier's stock valued at $40,000 after purchasing an additional 196 shares during the period. Finally, Kestra Advisory Services LLC acquired a new position in shares of Mesa Laboratories in the 4th quarter valued at about $55,000. Institutional investors own 90.60% of the company's stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc NASDAQ: MLAB is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company's product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.